Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association

RM Carey, DA Calhoun, GL Bakris, RD Brook… - …, 2018 - Am Heart Assoc
Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a
patient despite the concurrent use of 3 antihypertensive drug classes, commonly including a …

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in …

PK Whelton, RM Carey, WS Aronow, DE Casey… - Journal of the American …, 2018 - jacc.org
As early as the 1920s, and subsequently in the 1959 Build and Blood Pressure Study (S1. 5-
1) of almost 5 million adults insured between 1934 and 1954, a strong direct relationship …

Management of hypertension in chronic kidney disease

D Pugh, PJ Gallacher, N Dhaun - Drugs, 2019 - Springer
Chronic kidney disease (CKD) is an increasingly prevalent condition globally and is strongly
associated with incident cardiovascular disease (CVD). Hypertension is both a cause and …

Chronic kidney disease and cerebrovascular disease: consensus and guidance from a KDIGO controversies conference

DM Kelly, Z Ademi, W Doehner, GYH Lip, P Mark… - Stroke, 2021 - Am Heart Assoc
The global health burden of chronic kidney disease is rapidly rising, and chronic kidney
disease is an important risk factor for cerebrovascular disease. Proposed underlying …

Hypertension and cognitive impairment: a review of mechanisms and key concepts

M Canavan, MJ O'Donnell - Frontiers in Neurology, 2022 - frontiersin.org
Cognitive impairment, and dementia, are major contributors to global burden of death and
disability, with projected increases in prevalence in all regions of the world, but most marked …

Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations

JP Law, L Pickup, D Pavlovic, JN Townend… - Journal of Human …, 2023 - nature.com
Chronic kidney disease (CKD) is a complex condition with a prevalence of 10–15%
worldwide. An inverse-graded relationship exists between cardiovascular events and …

Hypertension in chronic kidney disease

SM Hamrahian, B Falkner - Hypertension: from basic research to clinical …, 2017 - Springer
Hypertension, a global public health problem, is currently the leading factor in the global
burden of disease. It is the major modifiable risk factor for heart disease, stroke and kidney …

The therapeutic potential of apelin in kidney disease

FA Chapman, D Nyimanu, JJ Maguire… - Nature Reviews …, 2021 - nature.com
Chronic kidney disease (CKD) is a leading cause of global morbidity and mortality and is
independently associated with cardiovascular disease. The mainstay of treatment for CKD is …

[HTML][HTML] Hypertension-related knowledge, practice and drug adherence among inpatients of a hospital in Samarkand, Uzbekistan

A Malik, Y Yoshida, T Erkin, D Salim… - Nagoya journal of …, 2014 - ncbi.nlm.nih.gov
Hypertension is one of the most important preventable causes of premature morbidity and
mortality in the world. Many people with hypertension both in developing and developed …

Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage

PE Drawz, AB Alper, AH Anderson… - Clinical Journal of the …, 2016 - journals.lww.com
Results The percentages of participants with controlled BP, white-coat, masked, and
sustained hypertension were 49.3%, 4.1%, 27.8%, and 18.8%, respectively. Compared with …